Why “reprogramming” is the buzziest approach to reversing aging right now

Life Biosciences has initiated a trial testing an experimental treatment for glaucoma by injecting a reprogramming therapy into a volunteer's eye to regenerate healthy nerves. The approach aims to reverse aging by resetting cells to a younger state, building on past strategies like targeting telomere attrition and cellular senescence, though recent trials of senescence clearance in humans showed mixed results.